Interleukin-18 increases expression of kinases involved in tau phosphorylation in SH-SY5Y neuroblastoma cells

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · see citing works

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961 · see citing works

Cloning of a new cytokine that induces IFN-γ production by T cells

Okamura, H., Tsutsui, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K., Okura, T., Nukada, Y., Hattori, K., et al. (1995) · Nature · doi:10.1038/378088a0 · Cited by 2,602 · see citing works

Diagnosis of Alzheimer's Disease

Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499 · see citing works

Neurodegenerative Tauopathies

Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480 · see citing works

Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model

Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208 · see citing works

Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration

Patrick, G. N., Zukerberg, L. R., Nikolić, M., de la Monte, S. M., Dikkes, P., & Tsai, L. (1999) · Nature · doi:10.1038/45159 · Cited by 1,541 · see citing works

Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease

Gómez‐Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C., Parisi, J. E., & Hyman, B. T. (1997) · Annals of Neurology · doi:10.1002/ana.410410106 · Cited by 1,489 · see citing works

The GSK3 hypothesis of Alzheimer’s disease

Hooper, C., Killick, R., & Lovestone, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05194.x · Cited by 1,191 · see citing works

Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease

Augustinack, J. C., Schneider, A., Mandelkow, E.-M., & Hyman, B. T. (2002) · Acta Neuropathologica · doi:10.1007/s004010100423 · Cited by 998 · see citing works

Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death.

Ohshima, T., Ward, J. M., Huh, C. G., Longenecker, G., Veeranna, Pant, H. C., Brady, R. O., Martin, L. J., & Kulkarni, A. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.11173 · Cited by 897 · see citing works

Glycogen synthase kinase-3 (GSK3): Inflammation, diseases, and therapeutics

Jope, R. S., Yuskaitis, C. J., & Beurel, E. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9128-5 · Cited by 774 · see citing works

Glial‐Neuronal Interactions in Alzheimer's Disease: The Potential Role of a ‘Cytokine Cycle’ in Disease Progression

Griffin, W., Sheng, J. G., Royston, M., Gentleman, S., McKenzie, J., Graham, D. I., Roberts, G., & Mrak, R. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00136.x · Cited by 751 · see citing works

Tau phosphorylation in neuronal cell function and dysfunction

Johnson, G. V. W., & Stoothoff, W. H. (2004) · Journal of Cell Science · doi:10.1242/jcs.01558 · Cited by 624 · see citing works

DNA Replication Precedes Neuronal Cell Death in Alzheimer's Disease

Yang, Y., Geldmacher, D., & Herrup, K. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02661.2001 · Cited by 607 · see citing works

The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation.Preprint

Nikolić, M., Dudek, H., Kwon, Y. T., Ramos, Y. F., & Tsai, L. (1996) · Genes & Development · doi:10.1101/gad.10.7.816 · Cited by 599 · see citing works

Interleukin-1 Mediates Pathological Effects of Microglia on Tau Phosphorylation and on Synaptophysin Synthesis in Cortical Neurons through a p38-MAPK Pathway

Li, Y., Liu, L., Barger, S. W., & Griffin, W. S. T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-05-01605.2003 · Cited by 563 · see citing works

Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms

Andorfer, C., Acker, C. M., Kress, Y., Hof, P. R., Duff, K., & Davies, P. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4637-04.2005 · Cited by 511 · cited 2× · see citing works

Intrathecal inflammation precedes development of Alzheimer's disease

Tarkowski, E. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.9.1200 · Cited by 501 · see citing works

Both the Establishment and the Maintenance of Neuronal Polarity Require Active Mechanisms

Jiang, H., Guo, W., Liang, X., & Rao, Y. (2005) · Cell · doi:10.1016/j.cell.2004.12.033 · Cited by 494 · see citing works

Cyclin G is a transcriptional target of the p53 tumor suppressor protein.

Okamoto, K., & Beach, D. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06807.x · Cited by 455 · see citing works

Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway

Quintanilla, R. A., Orellana, D. I., González-Billault, C., & Maccioni, R. B. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.01.002 · Cited by 455 · see citing works

Serine 15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2

Dumaz, N., & Meek, D. W. (1999) · The EMBO Journal · doi:10.1093/emboj/18.24.7002 · Cited by 455 · see citing works

Tau phosphorylation: physiological and pathological consequences

Stoothoff, W. H., & Johnson, G. V. W. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.06.017 · Cited by 439 · see citing works

Phosphorylation of Tau at Both Thr 231 and Ser 262 Is Required for Maximal Inhibition of Its Binding to Microtubules

Sengupta, A., Kabat, J., Novak, M., Wu, Q., Grundke-Iqbal, I., & Iqbal, K. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0813 · Cited by 363 · see citing works

Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease

Holmes, C. (2003) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.6.788 · Cited by 330 · see citing works

Reelin-mediated Signaling Locally Regulates Protein Kinase B/Akt and Glycogen Synthase Kinase 3β

Beffert, U., Morfini, G., Bock, H. H., Reyna, H., Brady, S. T., & Herz, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209205200 · Cited by 306 · see citing works

Regulation of GSK-3

Harwood, A. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00412-3 · Cited by 291 · see citing works

A Spatial Gradient of Tau Protein Phosphorylation in Nascent Axons

Mandell, J. W., & Banker, G. A. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-18-05727.1996 · Cited by 270 · see citing works

Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated ‘acute phase response’ in the brain?

Vandenabeele, P., & Fiers, W. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90032-o · Cited by 264 · see citing works

Tauopathies

Hernández, F., & Ávila, J. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7220-x · Cited by 263 · see citing works

Hyperphosphorylation of tau in PHF.

Morishima-kawashima, M., Hasegawa, M., Takio, K., Suzuki, M., Yoshida, H., Watanabe, A., Titani, K., & Ihara, Y. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00027-c · Cited by 238 · see citing works

Expression of interleukin-18 is increased in the brains of Alzheimer’s disease patients

Ojala, J., Alafuzoff, I., Herukka, S.-K., van Groen, T., Tanila, H., & Pirttilä, T. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.06.006 · Cited by 235 · see citing works

Involvement of cytokines in normal CNS development and neurological diseases: Recent progress and perspectives

Zhao, B., & Schwartz, J. P. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19980401)52:1 · Cited by 208 · see citing works

Brain interleukin-1 beta in Alzheimer's disease and vascular dementia.

Cacabelos, R., Alvarez, X. A., Fernández‐Novoa, L., Franco, A., Mangues, R., Pellicer, À., & Nishimura, T. (1994) · PubMed · Cited by 182 · see citing works

The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer’s disease-like tau phosphorylation

Jämsä, A., Hasslund, K., Cowburn, R. F., Bäckström, A., & Vasänge, M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.075 · Cited by 171 · see citing works

Levels of normal and abnormally phosphorylated tau in different cellular and regional compartments of Alzheimer disease and control brains

Khatoon, S., Grundke, I., & Iqbal, K. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00829-9 · Cited by 167 · see citing works

Neuronal cell cycle re-entry mediates Alzheimer disease-type changes

McShea, A., Lee, H., Petersen, R. B., Casadesús, G., Vincent, I. J., Linford, N. J., Funk, J.-O., Shapiro, R. A., & Smith, M. A. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.09.010 · Cited by 166 · see citing works

Cycling at the interface between neurodevelopment and neurodegeneration

Nguyen, M. D., Mushynski, W. E., & Julien, J. (2002) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401108 · Cited by 149 · see citing works

Glycogen Synthase Kinase-3 Plays a Crucial Role in Tau Exon 10 Splicing and Intranuclear Distribution of SC35

Hernández, F., Pérez, M., Lucas, J. J., Mata, A. M., Bhat, R. V., & Ávila, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311512200 · Cited by 135 · see citing works

Identification of p53 target genes through immune selection of genomic DNA: the cyclin G gene contains two distinct p53 binding sites.

Zauberman, A., Lupo, A., & Oren, M. (1995) · PubMed · Cited by 134 · see citing works

Characterisation of human cyclin G1 and G2: DNA damage inducible genes.

Bates, S. E., Rowan, S., & Vousden, K. H. (1996) · PubMed · Cited by 125 · see citing works

Association of interleukin‐18 expression with enhanced levels of both interleukin‐1β and tumor necrosis factor α in knee synovial tissue of patients with rheumatoid arthritis

Joosten, L. A. B., Radstake, T. R. D. J., Lubberts, E., van den Bersselaar, L. A. M., van Riel, P. L. C. M., van Lent, P. L. E. M., Barrera, P., & van den Berg, W. B. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10814 · Cited by 121 · see citing works

GAK: a cyclin G associated kinase contains a tensin/auxilin‐like domain1

Kanaoka, Y., Kimura, S. H., Okazaki, I., Ikeda, M., & Nojima, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01484-6 · Cited by 120 · see citing works

Binding of Interleukin-18 to the Interleukin-1 Receptor Homologous Receptor IL-1Rrp1 Leads to Activation of Signaling Pathways Similar to Those Used by Interleukin-1

Thomassen, E., Bird, T. A., Renshaw, B. R., Kennedy, M. K., & Sims, J. E. (1998) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1998.18.1077 · Cited by 119 · see citing works

Cyclin-dependent kinase 5 activity regulates pain signaling

Pareek, T. K., Keller, J., Kesavapany, S., Pant, H. C., Iadarola, M. J., Brady, R. O., & Kulkarni, A. B. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510405103 · Cited by 116 · see citing works

Interleukin 18 enhances Fas ligand expression and induces apoptosis in Fas-expressing human myelomonocytic KG-1 cells.

Ohtsuki, T., Micallef, M. J., Kohno, K., Tanimoto, T., Ikeda, M., & Kurimoto, M. (1997) · PubMed · Cited by 111 · see citing works

Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death

Lee, J.-H., Kim, H.-S., Lee, S., & Kim, K. (2007) · Journal of Cell Science · doi:10.1242/jcs.03468 · Cited by 108 · see citing works

Cell cycle-dependent phosphorylation and microtubule binding of tau protein stably transfected into Chinese hamster ovary cells.

Preuß, U., Döring, F., Illenberger, S., & Mandelkow�, E. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.10.1397 · Cited by 101 · see citing works

Functional studies of Alzheimer's disease tau protein

Lu, Q., & Jg, W. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-02-00508.1993 · Cited by 96 · see citing works

Discriminant power of combined cerebrospinal fluid τ protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease1Preliminary parts of this study have been presented in abstract form at the 6th International Conference on Alzheimer's Disease and Related Disorders, July 18–23, 1998, Amsterdam, The Netherlands and at the 28th Annual Meeting of the Society for Neuroscience, November 7–12, 1998, Los Angeles, CA, USA.1

Hampel, H. J., Teipel, S. J., Padberg, F., Haslinger, A., Riemenschneider, M., Schwarz, M., Kötter, H. U., Scheloske, M., Buch, K., Stübner, S., et al. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01146-4 · Cited by 93 · see citing works

Cell cycle regulatory failure in neurones: causes and consequences

Nagy, Z. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00223-2 · Cited by 92 · see citing works

Interleukin-18: Perspectives on the Newest Interleukin

Gillespie, M. T., & Horwood, N. J. (1998) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(98)00004-5 · Cited by 83 · see citing works

Sequential expression of mRNA for proinflammatory cytokines and interleukin-10 in the rat peripheral nervous system: Comparison between immune-mediated demyelination and wallerian degeneration

Gillen, C., Jander, S., & Stoll, G. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19980215)51:4 · Cited by 82 · see citing works

Role of cytokines in the gene expression of amyloid β–protein precursor: Identification of a 5'-UTR-Binding nuclear factor and its implications in Alzheimer's disease

Lahiri, D. K., Chen, D., Vivien, D., Ge, Y.-W., Greig, N. H., & Rogers, J. T. (2003) · Journal of Alzheimer s Disease · doi:10.3233/jad-2003-5203 · Cited by 81 · cited 2× · see citing works

Tau isoform expression and phosphorylation state during differentiation of cultured neuronal cells

Smith, C. J., Anderton, B. H., Davis, D. R., & Gallo, J. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01221-y · Cited by 78 · see citing works

An Essential Role for the Integrin-Linked Kinase–Glycogen Synthase Kinase-3β Pathway during Dendrite Initiation and Growth

Naska, S., Park, K. J., Hannigan, G. E., Dedhar, S., Miller, F. D., & Kaplan, D. R. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4462-06.2006 · Cited by 73 · see citing works

IL-6-mediated events in Alzheimer's disease pathology

Bauer, J., Strauss, S., Volk, B., & Berger, T. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90148-m · Cited by 62 · see citing works

Regional Expression of Key Cell Cycle Proteins in Brain from Subjects with Amnestic Mild Cognitive Impairment

Rukhsana Sultana, A., & Butterfield, D. A. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9123-x · Cited by 49 · see citing works

p53-Independent Cyclin G Expression in a Group of Mature Neurons and Its Enhanced Expression during Nerve Regeneration

Morita, N., Kiryu‐Seo, S., & Kiyama, A. H. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-19-05961.1996 · Cited by 47 · see citing works

Site-specific regulation of Alzheimer-like tau phosphorylation in living neurons

Burack, M. A., & Halpain, S. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00546-3 · Cited by 35 · see citing works

Developmental switch in the effects of TNFα on ventral midbrain dopaminergic neurons

Doherty, G. H. (2006) · Neuroscience Research · doi:10.1016/j.neures.2006.10.019 · Cited by 31 · see citing works

Proliferation and death of conditionally immortalized neural cells from murine neocortex: p53 alters the ability of neuron-like cells to re-enter the cell cycle

Miller, M. W., Peter, A. S., Wharton, S. B., & Wyllie, A. H. (2003) · Brain Research · doi:10.1016/s0006-8993(02)04119-7 · Cited by 13 · see citing works

Inhibition of the NGF and IL-1β-Induced Expression of Alzheimer's Amyloid Precursor Protein by Antisense Oligonucleotides

Chang, K., Kim, S., Kim, H.-S., Park, C., & Suh, Y. (1999) · Journal of Molecular Neuroscience · doi:10.1385/jmn:12:1:69 · Cited by 8 · see citing works

Alterations of cytoskeletal tau protein of SH-SY5Y human neuroblastoma cells after exposure to MPTP.

Song, X., & Ehrich, M. F. (1998) · PubMed · Cited by 6 · see citing works

Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets

Gao, C., Jiang, J., Tan, Y., & Chen, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01588-0 · Cited by 1,616 · see citing works

Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease.

(2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.03.49 · Cited by 1,288 · see citing works

Glial contributions to neurodegeneration in tauopathies

Leyns, C. E. G., & Holtzman, D. M. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0192-x · Cited by 409 · see citing works

Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome

Salminen, A., Kaarniranta, K., Kauppinen, A., Ojala, J. O., Haapasalo, A., Soininen, H. S., & Hiltunen, M. O. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.06.002 · Cited by 366 · see citing works

The Microbiota–Gut–Brain Axis and Alzheimer’s Disease: Neuroinflammation Is to Blame?

Megur, A., Baltriukienė, D., Bukelskienė, V., & Burokas, A. (2020) · Nutrients · doi:10.3390/nu13010037 · Cited by 323 · see citing works

Interleukin 18 in the CNS

Alboni, S., Cervia, D., Sugama, S., & Conti, B. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-9 · Cited by 301 · see citing works

The dual roles of cytokines in Alzheimer’s disease: update on interleukins, TNF-α, TGF-β and IFN-γ

Zheng, C., Zhou, X.-W., & Wang, J.-Z. (2016) · Translational Neurodegeneration · doi:10.1186/s40035-016-0054-4 · Cited by 292 · see citing works

The biological pathways of Alzheimer disease: a review

Calabrò, M., Rinaldi, C., Santoro, G., & Crisafulli, C. (2020) · AIMS neuroscience · doi:10.3934/neuroscience.2021005 · Cited by 271 · see citing works

Aging‐dependent changes of microglial cells and their relevance for neurodegenerative disorders

Von Bernhardi, R., Tichauer, J. E., & Eugenín, J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06537.x · Cited by 258 · see citing works

The neuroprotective effects of glucagon-like peptide 1 in Alzheimer’s and Parkinson’s disease: An in-depth review

Reich, N., & Hölscher, C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.970925 · Cited by 248 · see citing works

Pro-inflammatory interleukin-18 increases Alzheimer’s disease-associated amyloid-β production in human neuron-like cells

Sutinen, E. M., Pirttilä, T., Anderson, G., Salminen, A., & Ojala, J. O. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-199 · Cited by 228 · see citing works

The Link between Oxidative Stress, Mitochondrial Dysfunction and Neuroinflammation in the Pathophysiology of Alzheimer’s Disease: Therapeutic Implications and Future Perspectives

Jurcău, M. C., Andronie-Cioara, F. L., Jurcău, A., Marcu, F., Ţiț, D. M., Pașcalău, N., & Nistor-Cseppentö, D. C. (2022) · Antioxidants · doi:10.3390/antiox11112167 · Cited by 226 · see citing works

Intersection of pathological tau and microglia at the synapse

Vogels, T., Murgoci, A.-N., & Hromádka, T. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0754-y · Cited by 197 · see citing works

Impact of Cytokines and Chemokines on Alzheimer’s Disease Neuropathological Hallmarks

Domingues, C., Silva, O. A. B. D. C. E., & Henriques, A. G. (2017) · Current Alzheimer Research · doi:10.2174/1567205014666170317113606 · Cited by 212 · see citing works

Role of p38/MAPKs in Alzheimer's Disease: Implications for Amyloid Beta Toxicity Targeted Therapy

Kheiri, G., Dolatshahi, M., Rahmani, F., & Rezaei, N. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2018-0008 · Cited by 211 · see citing works

The role of inflammasome in Alzheimer's disease

Liu, L., & Chan, C. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2013.12.007 · Cited by 192 · see citing works

Neurodegenerative Disease and the NLRP3 Inflammasome

Holbrook, J. A., Jarosz-Griffiths, H., Caseley, E. A., Reyna, S. J. L., Poulter, J. A., Williams‐Gray, C. H., Peckham, D. G., & McDermott, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.643254 · Cited by 197 · see citing works

Influence of microglia and astrocyte activation in the neuroinflammatory pathogenesis of Alzheimer’s disease: Rational insights for the therapeutic approaches

Ahmad, M. H., Fatima, M., & Mondal, A. C. (2018) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2018.10.034 · Cited by 193 · see citing works

The involvement of NLRP3 inflammasome in the treatment of Alzheimer’s disease

Feng, Y.-S., Tan, Z., Wu, L., Dong, F., & Zhang, F. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101192 · Cited by 184 · see citing works

Molecular biomarkers for vascular cognitive impairment and dementia

Hosoki, S., Hansra, G. K., Jayasena, T., Poljak, A., Mather, K. A., Catts, V. S., Rust, R., Sagare, A. P., Kovacic, J. C., Brodtmann, A. G., et al. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00884-1 · Cited by 166 · see citing works

Schizophrenia: Linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression

Anderson, G., & Maes, M. H. J. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.06.014 · Cited by 144 · see citing works

The endotoxin hypothesis of Alzheimer’s disease

Brown, G. C., & Heneka, M. T. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00722-y · Cited by 140 · see citing works

Inflammasomes as therapeutic targets for A lzheimer's disease

White, C., Lawrence, C. B., Brough, D., & Rivers‐Auty, J. (2016) · Brain Pathology · doi:10.1111/bpa.12478 · Cited by 131 · see citing works

The Role of Neuronal NLRP1 Inflammasome in Alzheimer’s Disease: Bringing Neurons into the Neuroinflammation Game

Yap, J. K. Y., Pickard, B. S., Chan, E. W. L., & Gan, S. Y. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1638-7 · Cited by 127 · see citing works

The effect of insomnia on development of Alzheimer’s disease

Sadeghmousavi, S., Eskian, M., Rahmani, F., & Rezaei, N. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01960-9 · Cited by 113 · see citing works

Increased Serum Levels of Interleukin-18, -23 and -17 in Chinese Patients with Alzheimer's Disease

Chen, J., Jiang, G., Li, Q., Zhou, Z., & Cheng, Q. H. (2014) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000360606 · Cited by 97 · see citing works

Neuroinflammatory Signaling in the Pathogenesis of Alzheimer’s Disease

Uddin, M. S., Kabir, M. T., Jalouli, M., Rahman, M. A., Jeandet, P., Behl, T., Alexiou, A. T., Albadrani, G. M., Abdel‐Daim, M. M., Perveen, A., et al. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210826130210 · Cited by 76 · see citing works

Integrated communications between cyclooxygenase‐2 and Alzheimer's disease

Guan, P.-P., & Wang, P. (2018) · The FASEB Journal · doi:10.1096/fj.201800355rrrr · Cited by 70 · see citing works

Manganese Induces Tau Hyperphosphorylation through the Activation of ERK MAPK Pathway in PC12 Cells

Cai, T., Che, H., Yao, T. S., Chen, Y., Huang, C., Zhang, W., Du, K., Zhang, J., Cao, Y., Chen, J., et al. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq308 · Cited by 67 · see citing works

Molecular Mechanisms Underlying Neuroinflammation Elicited by Occupational Injuries and Toxicants

Pathak, D., & Sriram, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032272 · Cited by 69 · see citing works

Inflammasome Involvement in Alzheimer’s Disease

Olsen, I., & Singhrao, S. K. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160197 · Cited by 66 · see citing works

The Role of Interleukin-18, Oxidative Stress and Metabolic Syndrome in Alzheimer’s Disease

Ojala, J. O., & Sutinen, E. M. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6050055 · Cited by 64 · see citing works

Ferroptosis, Pyroptosis, and Cuproptosis in Alzheimer’s Disease

Wang, Q., Sun, J., Chen, T., Song, S., Hou, Y., Feng, L., Fan, C., & Li, M. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00343 · Cited by 62 · see citing works

Targeting Cdk5 Activity in Neuronal Degeneration and Regeneration

Kanungo, J., Zheng, Y., Amin, N. D., & Pant, H. C. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9410-6 · Cited by 59 · see citing works

Suppression of LPS-induced tau hyperphosphorylation by serum amyloid A

Liu, J., Wang, D., Li, S.-Q., Yu, Y., & Ye, R. D. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0493-y · Cited by 58 · see citing works

Interaction between hyperphosphorylated tau and pyroptosis in forskolin and streptozotocin induced AD models

Li, Y., Xu, P., Shan, J., Sun, W., Ji, X., Chi, T., Liu, P., & Zou, L. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109618 · Cited by 52 · see citing works

Synergistic Actions of Microglia and Astrocytes in the Progression of Alzheimer's Disease

Bouvier, D. S., & Murai, K. K. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-143156 · Cited by 51 · see citing works

Phosphorylation of TRPV1 by cyclin-dependent kinase 5 promotes TRPV1 surface localization, leading to inflammatory thermal hyperalgesia

Liu, J., Du, J., Yang, Y., & Wang, Y. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.09.005 · Cited by 46 · see citing works

Long-term maternal separation potentiates depressive-like behaviours and neuroinflammation in adult male C57/BL6J mice

Zhou, L., Wu, Z., Wang, G., Xiao, L., Wang, H., Sun, L., & Xie, Y. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.172953 · Cited by 46 · see citing works

Selenium-containing compounds: a new hope for innovative treatments in Alzheimer’s disease and Parkinson’s disease

Pyka, P., Garbo, S., Fioravanti, R., Jacob, C., Hittinger, M., Handzlik, J., Zwergel, C., & Battistelli, C. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104062 · Cited by 46 · see citing works

PI3K/AKT/GSK3β/CRMP-2-mediated neuroplasticity in depression induced by stress

Wu, Z., Wang, G., Wei, Y., Xiao, L., & Wang, H. (2018) · Neuroreport · doi:10.1097/wnr.0000000000001096 · Cited by 44 · see citing works

Interleukin-18 directly protects cortical neurons by activating PI3K/AKT/NF-κB/CREB pathways

Zhou, J., Ping, F., Lv, W.-T., Feng, J.-Y., & Shang, J. (2014) · Cytokine · doi:10.1016/j.cyto.2014.05.003 · Cited by 43 · see citing works

Mitochondrial DNA and Inflammation in Alzheimer’s Disease

Galizzi, G., & Carlo, M. D. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45110540 · Cited by 42 · see citing works

Interleukin-18 modulation in autism spectrum disorders

Businaro, R., Corsi, M., Azzara, G., Raimo, T. D., Giovanni Laviola, A., Romano, E., Ricci, L., Maccarrone, M., Aronica, E., Fuso, A., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0466-6 · Cited by 39 · see citing works

The Dichotomous Role of Inflammation in the CNS: A Mitochondrial Point of View

Vezzani, B., Carinci, M., Patergnani, S., Pasquin, M., Guarino, A., Aziz, N., Pinton, P., Simonato, M., & Giorgi, C. (2020) · Biomolecules · doi:10.3390/biom10101437 · Cited by 40 · see citing works

N-acetyl-cysteine prevents toxic oxidative effects induced by IFN-α in human neurons

Alboni, S., Gibellini, L., Montanari, C., Benatti, C., Benatti, S., Tascedda, F., Brunello, N., Cossarizza, A., & Pariante, C. M. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000266 · Cited by 35 · see citing works

Interleukin-18 alters protein expressions of neurodegenerative diseases-linked proteins in human SH-SY5Y neuron-like cells

Sutinen, E. M., Korolainen, M. A., Häyrinen, J., Alafuzoff, I., Petratos, S., Salminen, A., Soininen, H., Pirttilä, T., & Ojala, J. O. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00214 · Cited by 34 · see citing works

Altered interleukin-18 levels are associated with cognitive impairment in chronic schizophrenia

Wu, J. Q., Chen, D. C., Tan, Y., Tan, S., Xiu, M. H., Wang, Z. R., Yang, F. D., Soares, J. C., & Zhang, X. Y. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.01.013 · Cited by 34 · see citing works

Latest Perspectives on Alzheimer’s Disease Treatment: The Role of Blood-Brain Barrier and Antioxidant-Based Drug Delivery Systems

Daraban, B. S., Popa, A. S., & Stan, M. S. (2024) · Molecules · doi:10.3390/molecules29174056 · Cited by 36 · see citing works

The Potential Role of Protein Kinase R as a Regulator of Age-Related Neurodegeneration

Martínez, N. W., Gómez, F. E., & Matus, S. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.638208 · Cited by 31 · see citing works

Alzheimer's and Seizures: Interleukin-18, Indoleamine 2,3-Dioxygenase and Quinolinic Acid

Anderson, G., & Ojala, J. O. (2010) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s4603 · Cited by 32 · see citing works

p47phox deficiency improves cognitive impairment and attenuates tau hyperphosphorylation in mouse models of AD

Gong, P., Chen, Y.-Q., Lin, A.-H., Zhang, H.-B., Zhang, Y., Ye, R. D., & Yu, Y. (2020) · Alzheimer's Research & Therapy · doi:10.1186/s13195-020-00714-2 · Cited by 29 · see citing works

Advances in the Understanding of the Correlation Between Neuroinflammation and Microglia in Alzheimer’s Disease

Yan, H., Wang, W., Cui, T., Shao, Y., Li, M., Fang, L., & Feng, L. (2024) · ImmunoTargets and Therapy · doi:10.2147/itt.s455881 · Cited by 30 · see citing works

Molecular roles of Cdk5 in pain signaling

Utreras, E., Futatsugi, A., Pareek, T. K., & Kulkarni, A. B. (2009) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2009.04.004 · Cited by 28 · see citing works

Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of central nervous system diseases

Liu, D., Ander, B. P., & Sharp, F. R. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.013 · Cited by 27 · see citing works

Is Targeting the Inflammasome a Way Forward for Neuroscience Drug Discovery?

Swanton, T., Cook, J., Beswick, J. A., Freeman, S., Lawrence, C. B., & Brough, D. (2018) · SLAS DISCOVERY · doi:10.1177/2472555218786210 · Cited by 25 · see citing works

Molecular Mechanisms of IL18 in Disease

Yamanishi, K., Hata, M., Gamachi, N., Watanabe, Y., Yamanishi, C., Okamura, H., & Matsunaga, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417170 · Cited by 24 · see citing works

Electroacupuncture at ST 36 ameliorates cognitive impairment and beta-amyloid pathology by inhibiting NLRP3 inflammasome activation in an Alzheimer’s disease animal model

Ni, H., Ren, J., Wang, Q., Li, X., Wu, Y. H., Liu, D., & Wang, J. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16755 · Cited by 22 · see citing works

Fibrillar Amyloid-β Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3×Tg-AD Transgenic Mouse

Ontiveros‐Torres, M. Á., Labra‐Barrios, M. L., Díaz-Cintra, S. Y., Aguilar-Vázquez, A. R., Moreno-Campuzano, S., Flores-Rodríguez, P., Luna-Herrera, C., Mena, R., Perry, G. L., Florán, B., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150837 · Cited by 21 · see citing works

Mitochondrion-based organellar therapies for central nervous system diseases

Zhao, M., Wang, J., Zhu, S., Wang, M., Chen, C., Wang, L., & Liu, J. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01843-z · Cited by 20 · see citing works

Elevated levels of IL‐18 associated with schizophrenia and first episode psychosis: A systematic review and meta‐analysis

Syed, A. A. S., He, L., Shi, Y.-Y., & Mahmood, S. (2020) · Early Intervention in Psychiatry · doi:10.1111/eip.13031 · Cited by 19 · see citing works

Brain interleukins and Alzheimer’s disease

Abdelhamed, H. G., Hassan, A. A., Sakraan, A., Al-Deeb, R. T., Mousa, D. M., Ezz, H. S. A., Noor, N. A., Khadrawy, Y. A., & Radwan, N. M. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01538-5 · Cited by 20 · see citing works

Natural products as potential modulators of pro-inflammatory cytokines signalling in Alzheimer's disease

Yadav, V., Mythri, C., & Kumarasamy, M. (2024) · Brain Behavior and Immunity Integrative · doi:10.1016/j.bbii.2024.100048 · Cited by 18 · see citing works

Exerkines mitigating Alzheimer's disease progression by regulating inflammation: Focusing on macrophage/microglial NLRP3 inflammasome pathway

Cheon, J., Kwon, S.-Y., & Kim, M. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14432 · Cited by 18 · see citing works

Resilience in the LPS-induced acute depressive-like behaviors: Increase of CRMP2 neuroprotection and microtubule dynamics in hippocampus

Wu, Z., Wang, G., Xiao, L., Wei, Y., Wang, H., Zhou, L., & Sun, L. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.06.015 · Cited by 16 · see citing works

Glial profiling of human tauopathy brain demonstrates enrichment of astrocytic transcripts in tau-related frontotemporal degeneration

Johnson, A. G., Webster, J. A., & Hales, C. M. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.12.005 · Cited by 16 · see citing works

Differentiation of Human SH-SY5Y Neuroblastoma Cells by All- Trans Retinoic Acid Activates the Interleukin-18 System

Sallmon, H., Hoene, V., Weber, S. C., & Dame, C. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2009.0036 · Cited by 14 · see citing works

Lipopolysaccharide induced neuroprotective effects of bacterial protease against Alzheimer's disease in male Wistar albino rats

Azzam, S. M., Rahman, A. A. S. A., Ahmed-Farid, O. A.-H., El-Wafa, W. M. A., & Salem, G. E. M. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123260 · Cited by 12 · see citing works

ERα36 gene silencing promotes tau protein phosphorylation, inhibits cell proliferation, and induces apoptosis in human neuroblastoma SH‐SY5Y cells

Wang, H., Li, T., Ma, D., & Zhi, H. (2018) · The FASEB Journal · doi:10.1096/fj.201701386 · Cited by 12 · see citing works

Interleukin 18 and the brain: neuronal functions, neuronal survival and psycho-neuro-immunology during stress

Alboni, S., Tascedda, F., Uezato, A., Sugama, S., Chen, Z., Marcondes, M. C. G., & Conti, B. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-02951-z · Cited by 13 · see citing works

Plasma levels of Interleukin 18 but not amyloid-β or Tau are elevated in female depressive patients

Liu, F., Yang, L., Zheng, H. S., Zhou, Y., Chen, B.-B., Xu, H., Zhang, Y., & Shen, D. (2020) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2020.152159 · Cited by 10 · see citing works

Tailoring MAPK Pathways: New Therapeutic Avenues for Treating Alzheimer’s Disease

Sharma, A., Mehra, V., Kumar, V., Jain, A., & Prakash, H. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04919-0 · Cited by 10 · see citing works

Microbiota and Alzheimer’s disease: mechanistic insights from a multi-organ perspective

Liao, J., Mou, H., Luo, S., Shen, L., & Jiao, B. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00541-9 · Cited by 10 · see citing works

Glycogen Synthase Kinase-3β, NLRP3 Inflammasome, and Alzheimer’s Disease

Jia, Y.-R., Guo, Z.-Q., Guo, Q., & Wang, X. (2023) · Current Medical Science · doi:10.1007/s11596-023-2788-4 · Cited by 9 · see citing works

Prostaglandin A1 Decreases the Phosphorylation of Tau by Activating Protein Phosphatase 2A via a Michael Addition Mechanism at Cysteine 377

Xu, G., Guan, P.-P., & Wang, P. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02174-z · Cited by 7 · see citing works

Interleukin-18 −137 G/C and −607 C/A polymorphisms and Alzheimer’s disease risk: a meta-analysis

Zhang, J., Song, T., Liang, H., Lian, J., Zhang, G., & Gong, H. (2016) · Neurological Sciences · doi:10.1007/s10072-016-2516-y · Cited by 7 · see citing works

Protein profiling of SH-SY5Y neuroblastoma cells: The effect of rhein

Čočková, Z., Ujčíková, H., Telenský, P., & Novotný, J. (2019) · Journal of Biosciences · doi:10.1007/s12038-019-9908-0 · Cited by 7 · see citing works

Neuroimmune Dynamics in Alzheimer’s Disease Progression

Andrade, V., Guzmán‐Martínez, L., Vergara-Pulgar, K., & Maccioni, R. B. (2017) · InTech eBooks · doi:10.5772/intechopen.68941 · Cited by 4 · see citing works

Cognitive Impairment in Parasitic Protozoan Infection

Chakroborty, N. K., Baksi, S., & Bhattacharya, A. (2023) · Springer eBooks · doi:10.1007/978-981-19-8225-5_4 · Cited by 3 · see citing works

Identification of plasma inflammatory biomarkers for Alzheimer’s disease reveals IFN-γ as a regulator of ACSL1-mediated microglia phenotype

Huang, R., Lin, B.-B., Lu, Z., Hao, Y., Li, C. F., Lin, Z., Zhang, Y., Wei, N., & Chen, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1770509 · Cited by 3 · see citing works

Astrocytic lipidopathy and bioenergetic failure in ApoE4-associated late-onset Alzheimer's disease: A unifying hypothesis

Garrahy, J. P. (2025) · Journal of Alzheimer's Disease · doi:10.1177/13872877251350338 · Cited by 6 · see citing works

The Crosstalk Between Protective and Detrimental Interleukin (IL)‐1 Family of Cytokines in Alzheimer's Disease

Liu, T., & Li, X. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70460 · Cited by 3 · see citing works

Fine structure of interleukin 18 (IL-18) receptor-immunoreactive neurons in the retrosplenial cortex and its changes in IL18 knockout mice

Hayakawa, T., Hata, M., Kuwahara‐Otani, S., Yamanishi, K., Yagi, H., & Okamura, H. (2016) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2016.08.009 · Cited by 3 · see citing works

Inhibition of the Transforming Growth Factor‐β Signaling Pathway Confers Neuroprotective Effects on Beta‐Amyloid‐Induced Direct Neurotoxicity and Microglia‐Mediated Neuroinflammation

Tiong, S. Q., Mohgan, R., Quek, J. Y., Liew, J. Y. S., Wong, G. Y. S., Thang, Z. Q., Chan, Z. L., Gan, S. Y., & Chan, E. W. L. (2025) · Neurology Research International · doi:10.1155/nri/8948290 · Cited by 3 · see citing works

Electroacupuncture ameliorates tau-driven cognitive decline by modulating NF-κB/NLRP3 inflammasome signaling in P301S mice

Zheng, R., Liu, X., Liao, Z., Wan, R., Qiu, G., Min, L. I., Tang, C., Zhou, R., & Song, J. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115637 · Cited by 2 · see citing works

Exercise training mitigates age-related cognitive decline by attenuating TMAO-induced inflammation

Zhang, R., Li, L., Xi, X., Zhu, Z., Dai, T., & Gong, W. (2026) · Scientific Reports · doi:10.1038/s41598-026-36354-z · Cited by 2 · see citing works

Amyloid PET scan diagnosis of Alzheimer’s disease in patients with multiple sclerosis: a scoping review study

Khalafi, M., Rashnoudi, A. R., Rahmani, F., Javanmardi, P., Panahi, P., Shahvandi, H. K., Tajik, M. H., Soleimantabar, H., & Shirbandi, K. (2023) · The Egyptian Journal of Radiology and Nuclear Medicine · doi:10.1186/s43055-023-00964-8 · Cited by 2 · see citing works

Tau Phosphorylation

Ávila, J., & Hernández, F. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-6787-9_3 · Cited by 2 · see citing works

Features of molecule expression markers of insulin resistance in experimental Alzheimer’s disease

Gorina, Y. V., Komleva, Y. K., Lopatina, O. L., Volkova, V. V., Gersog, G. E., Popova, N. N., & Salmina, A. B. (2015) · Problems of Endocrinology · doi:10.14341/probl201561443-48 · Cited by 2 · see citing works

Exploring GPR120/FFAR4 pharmacology: Unveiling novel therapeutic avenues through molecular signaling pathways for Alzheimer's disease intervention

Gogu, P., Bharti, J., Yadav, J. P., Grishina, M., Verma, A., Kumar, V., Singh, A. K., Verma, A., Kumar, P., Khalilullah, H., et al. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.101061 · Cited by 1 · see citing works

IL-18 binding protein attenuates neuroinflammation and cognitive decline in Alzheimer’s disease

Hong, D. K., Jeon, S. H., Kang, M., Lee, S., Liu, X., Ahn, E. H., & Kang, S. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03720-7 · Cited by 1 · see citing works

Prostaglandin A1 inhibits the phosphorylation of tau via activating protein phosphotase 2A in a michael addition mechanism at the site of cysteine 377Preprint

Xu, G., Guan, P.-P., & Wang, P. (2020) · Research Square · doi:10.21203/rs.3.rs-56068/v1 · Cited by 1 · see citing works

Mechanisms of palmitate induced amyloidogenesis in Alzheimer's Disease mediated by astrocytes

Liu, L. (2013) · doi:10.25335/hzqa-1c05

The Role of Microglial-Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) in Neuronal Homeostasis and Tau Pathogenesis

Jadhav, V. (2021) · IUScholarWorks (Indiana University) · doi:10.7912/c2/2086

Ação neuroprotetora do ginseng brasileiro Pfaffia glomerata (Spreng.) Pedersen

Franco, R. R. (2021) · doi:10.14393/ufu.te.2021.575

Perspective Chapter: Alzheimer - A Complex Genetic Background

Calabrò, M., & Crisafulli, C. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.101455

Electroacupuncture Ameliorates Cognitive Impairment and Beta-Amyloid Pathology Via Inhibiting the Activation of NLRP3 Inflammasome in an Alzheimer's Disease AnimalPreprint

Ni, H., Ren, J., Li, X., Wang, J., & Liu, G. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4198951

Additional file 1 of p47phox deficiency improves cognitive impairment and attenuates tau hyperphosphorylation in mouse models of AD

Gong, P., Chen, Y.-Q., Lin, A.-H., Zhang, H.-B., Zhang, Y., Ye, R. D., & Yu, Y. (2020) · Figshare · doi:10.6084/m9.figshare.13233231

Additional file 1 of Amyloid PET scan diagnosis of Alzheimer’s disease in patients with multiple sclerosis: a scoping review study

Khalafi, M., Rashnoudi, A. R., Rahmani, F., Javanmardi, P., Panahi, P., Kiani Shahvandi, H., Tajik, M. H., Soleimantabar, H., & Shirbandi, K. (2023) · Figshare · doi:10.6084/m9.figshare.22604738

Plasticity of hippocampal synaptic transmission and intrinsic excitability in a mouse model of Alzheimer’s disease

Jiang, N. (2019) · theses.fr (ABES) · doi:10.70675/e788b268zc8e3z491az8d02z52080880e988

P3‐369: Interleukin‐18 increases expression of kinases involved in tau phosphorylation in SH‐SY5Y neuroblastoma cells

Ojala, J. O., Sutinen, E. M., & Pirttilä, T. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.1939

Interleukin-18 alters protein expressions of neurodegenerative diseases-linked proteins in human SH-SY5Y neuron-like cells

Sutinen, E. M., Korolainen, M. A., Häyrinen, J., Alafuzoff, I., Petratos, S., Salminen, A., Soininen, H., Pirttilä, T., & Ojala, J. O. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00214 · Cited by 34 · see citing works

Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway

Quintanilla, R. A., Orellana, D. I., González-Billault, C., & Maccioni, R. B. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.01.002 · Cited by 455 · see citing works

Pro-inflammatory interleukin-18 increases Alzheimer’s disease-associated amyloid-β production in human neuron-like cells

Sutinen, E. M., Pirttilä, T., Anderson, G., Salminen, A., & Ojala, J. O. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-199 · Cited by 228 · see citing works

Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylation

Sheng, J. G., Jones, R. A., Zhou, X. Q., McGinness, J. M., Van Eldik, L. J., Mrak, R. E., & Griffin, W. S. T. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00041-9 · Cited by 176 · see citing works